These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 21298652)
1. STEMI patients--the more you bleed, the more you die: a comparison between classifications. Valente S; Lazzeri C; Chiostri M; Osmanagaj L; Giglioli C; Gensini GF Clin Cardiol; 2011 Feb; 34(2):90-6. PubMed ID: 21298652 [TBL] [Abstract][Full Text] [Related]
2. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. Mehran R; Pocock S; Nikolsky E; Dangas GD; Clayton T; Claessen BE; Caixeta A; Feit F; Manoukian SV; White H; Bertrand M; Ohman EM; Parise H; Lansky AJ; Lincoff AM; Stone GW JACC Cardiovasc Interv; 2011 Jun; 4(6):654-64. PubMed ID: 21700252 [TBL] [Abstract][Full Text] [Related]
3. A risk score to predict bleeding in patients with acute coronary syndromes. Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595 [TBL] [Abstract][Full Text] [Related]
4. Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction. Vranckx P; Campo G; Anselmi M; Bolognese L; Colangelo S; Biondi-Zoccai G; Moreno R; Piva T; Favero L; Prati F; Nazzaro M; Díaz Fernández JF; Ferrari R; Valgimigli M; EuroIntervention; 2012 May; 8(1):71-8. PubMed ID: 22311867 [TBL] [Abstract][Full Text] [Related]
5. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry. Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352 [TBL] [Abstract][Full Text] [Related]
6. Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center. Barthélémy O; Silvain J; Brieger D; Mercadier A; Lancar R; Bellemain-Appaix A; Beygui F; Collet JP; Costagliola D; Montalescot G Catheter Cardiovasc Interv; 2012 Jan; 79(1):104-12. PubMed ID: 22162411 [TBL] [Abstract][Full Text] [Related]
7. Use, efficacy and safety of prasugrel in patients with ST segment elevation myocardial infarction scheduled for primary percutaneous coronary intervention in clinical practice. Results of the prospective ATACS-registry. Zeymer U; Hochadel M; Lauer B; Kaul N; Wöhrle J; Andresen D; Schwimmbeck P; Solzbach U; Thiele H; Gitt A; Diller F; Zahn R Int J Cardiol; 2015 Apr; 184():122-127. PubMed ID: 25703419 [TBL] [Abstract][Full Text] [Related]
15. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials. Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052 [TBL] [Abstract][Full Text] [Related]
16. Risk definition and outcomes with the application of the PEGASUS-TIMI 54 trial inclusion criteria to a "real world" STEMI population: results from the Italian "CARDIO-STEMI SANREMO" registry. Sanchez F; Boasi V; Vercellino M; Tacchi C; Cannarile P; Pingelli N; Perri D; Gomez L; Cattunar S; Mascelli G BMC Cardiovasc Disord; 2021 Mar; 21(1):144. PubMed ID: 33736607 [TBL] [Abstract][Full Text] [Related]
17. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy). Robertson JO; Ebrahimi R; Lansky AJ; Mehran R; Stone GW; Lincoff AM JACC Cardiovasc Interv; 2014 Apr; 7(4):372-9. PubMed ID: 24630881 [TBL] [Abstract][Full Text] [Related]
18. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. Verheugt FW; Steinhubl SR; Hamon M; Darius H; Steg PG; Valgimigli M; Marso SP; Rao SV; Gershlick AH; Lincoff AM; Mehran R; Stone GW JACC Cardiovasc Interv; 2011 Feb; 4(2):191-7. PubMed ID: 21349458 [TBL] [Abstract][Full Text] [Related]
19. Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry. Hibbert B; MacDougall A; Labinaz M; O'Brien ER; So DY; Dick A; Glover C; Froeschl M; Marquis JF; Wells GA; Blondeau M; Le May MR Circ Cardiovasc Interv; 2012 Dec; 5(6):805-12. PubMed ID: 23149331 [TBL] [Abstract][Full Text] [Related]